From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia

Bosch-Schips, Jan; Nadeu, Ferran; Cabirta, Alba; Bosch, Francesc; Abrisqueta, Pau; IACOBONI, GLORIA; Serna, Angel

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Bosch-Schips, Jan
dc.contributor.author	Nadeu, Ferran
dc.contributor.author	Cabirta, Alba
dc.contributor.author	Bosch, Francesc
dc.contributor.author	Abrisqueta, Pau
dc.contributor.author	IACOBONI, GLORIA
dc.contributor.author	Serna, Angel
dc.date.accessioned	2023-09-19T08:28:40Z
dc.date.available	2023-09-19T08:28:40Z
dc.date.issued	2023-11
dc.identifier.citation	Abrisqueta P, Nadeu F, Bosch-Schips J, Iacoboni G, Serna A, Cabirta A, et al. From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia. Cancer Treat Rev. 2023 Nov;120:102619.
dc.identifier.issn	0305-7372
dc.identifier.uri	https://hdl.handle.net/11351/10286
dc.description	Leucèmia limfocítica crònica; Evolució clonal; Transformació de Richter
dc.description.sponsorship	This work was supported in part by the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias [PI17/00943, F.B, PI18/01392, P.A.], and Gilead Fellowships, United States [GLD18/00047, F.B.] and Fundació la Marató de TV3, Spain [201905-30-31 F.B]. F.N. acknowledges research support from the American Association for Cancer Research (2021 AACR-Amgen Fellowship in Clinical/Translational Cancer Research, 21-40-11-NADE), the European Hematology Association (EHA Junior Research Grant 2021, RG-202012-00245), the Lady Tata Memorial Trust, India (International Award for Research in Leukaemia 2021–2022, LADY_TATA_21_3223).
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartofseries	Cancer Treatment Reviews;120
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Leucèmia limfocítica crònica - Complicacions
dc.subject	Trastorns limfoproliferatius - Tractament
dc.subject.mesh	Leukemia, Lymphocytic, Chronic, B-Cell
dc.subject.mesh	/complications
dc.subject.mesh	Lymphoma, Large B-Cell, Diffuse
dc.subject.mesh	/therapy
dc.title	From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.ctrv.2023.102619
dc.subject.decs	leucemia linfocítica crónica de células B
dc.subject.decs	/complicaciones
dc.subject.decs	linfoma de células B grandes difuso
dc.subject.decs	/terapia
dc.relation.publishversion	https://doi.org/10.1016/j.ctrv.2023.102619
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Abrisqueta P, Iacoboni G, Serna A, Cabirta A, Bosch F] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Nadeu F] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Department of Pathology, Hospital Universitari de Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. [Bosch-Schips J] Department of Pathology, Hospital Universitari de Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain
dc.identifier.pmid	37660626
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F01392
dc.rights.accessrights	info:eu-repo/semantics/openAccess